Microvast: Sell On Abysmal Results And Persistent Headwinds

Microvast reported disappointing first-quarter results, with sales missing expectations by a wide margin, negative adjusted EBITDA, and a sizeable cash burn. MVST's backlog declined by another 14% sequentially to $168.7 million, a new multi-year low for Microvast. The company's book-to-bill ratio was well below 1.0 for the fifth consecutive quarter. Stricter safety mandates and reduced subsidies are impacting the company's sales in key Asian markets like South Korea and India.